Invention Grant
- Patent Title: Method of treating psoriatic arthritis with increased interval dosing of anti-IL12/23 antibody
-
Application No.: US16993556Application Date: 2020-08-14
-
Publication No.: US11197913B2Publication Date: 2021-12-14
- Inventor: Marc Chevrier , Kamyar Farahi , Newman Yeilding
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Riverside Law LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61K38/20 ; A01K67/027 ; A61K39/00 ; C07K14/54 ; A61K35/12
Abstract:
A method of treating an IL-12/23-related disease in a patient using an increasing dosing interval, comprises increasing the dosing interval of IL-12/IL-23 antibody to a patient, wherein the antibody is administered initially and after 4 weeks, after 16 weeks and after 28 weeks, and increasing the dosing interval after 28 weeks to an increased interval, e.g., every 16, 20 or 24 weeks.
Information query
